Nupur Kokta

Sir thank you for the opportunity. My first question is like we had four validated CDMO products, which were expected to start contributing to revenue this year. Could you share the specific time lines and commercial ramp-up curve for these products? And also additionally, like we have a CDMO revenue target of INR1,000 crores maybe by FY '28. So what percentage of this target is backed currently?

Okay. My second question is, when do we expect our commercial revenue recognition to begin from the electrolyte additive capacity that we inaugurated this year?

Okay. So like trial revenues are done and the products are to be commercialized very soon. So commercial revenue would begin soon, right?